I have started this thread to continue the discussion about possible phospholipid disruption in ME/CFS started in a different thread. @mariovitali mentioned some research papers that indicate phospholipid dysregulation-
I would like to add a few other observations that may be relevant. In the Ron Davis oxidative stress paper, they suggest there is evidence of phospholipid disruption-
https://www.pnas.org/doi/10.1073/pnas.2426564122
They found increased LysoPE in ME/CFS patients, which is the product of hydrolysis of Phosphatidylethanolamine (PE). It's possible that the reason for this is that there may be increased PE in the membrane relative to PC, either due to excessive PC hydrolysis, or reduced conversion of PE to PC, or both.
Also, looking through the Precision Life analysis of the DecodeME data, they found 7,555 unique SNPs and one of those is PEMT rs66637059, which converts PE to PC in the liver.
In addition, @DMissa published research showing PC(0-38:4) is lower in ME/CFS LCLs.
I personally have the gene variant of PEMT rs12325817 which reduces the ability to upregulate PEMT expression in response to estrogen. I'm not sure if common PEMT variants like rs12325817 and rs7946 were looked at in the DecodeME study @Simon M @Chris Ponting
When I was ill with ME I used to get postprandial hypoglycemia at about 40 minutes after eating a meal, and starting to supplement phosphatidylcholine stopped this- I was wearing a continuous glucose monitor at the time so I could see the hypoglycemias. What is interesting is that for long before I developed ME at age 32 I had been sensitive to carbohydrates and would feel very sleepy after eating high glycemic index foods and this sensitivity to carbohydrates got progressively worse in my late 20s, which is interesting as estrogen in women decreases in late 20s/early 30s, which I may have been more vulnerable to with a PEMT variant which makes PEMT less responsive to estrogen.
There is not much research on how phosphatidylcholine affects insulin receptor sensitivity, but there is a study which indicates that reduced PC in the membrane can increase insulin receptor sensitivity, potentially contributing to faster glucose uptake which could have contributed to my post prandial hypoglycemia.
https://diabetesjournals.org/diabet.../Inhibiting-Phosphatidylcholine-Remodeling-in
The reason it's interesting to me is that this was one of the few issues I had when I was still a relatively healthy person, long before I developed ME which makes me think that reduced PC synthesis might be more likely to be a contributing root cause rather than a downstream consequence of whatever is causing ME.
My suspicion is that getting both Covid and then a head injury within 6 months of each other led to increased PLA2 activation which increased PC hydrolysis, and because I already had a problem with PC synthesis, this pushed me past a threshold to create a serious PC deficiency.
I would like to add a few other observations that may be relevant. In the Ron Davis oxidative stress paper, they suggest there is evidence of phospholipid disruption-
https://www.pnas.org/doi/10.1073/pnas.2426564122
They found increased LysoPE in ME/CFS patients, which is the product of hydrolysis of Phosphatidylethanolamine (PE). It's possible that the reason for this is that there may be increased PE in the membrane relative to PC, either due to excessive PC hydrolysis, or reduced conversion of PE to PC, or both.
Also, looking through the Precision Life analysis of the DecodeME data, they found 7,555 unique SNPs and one of those is PEMT rs66637059, which converts PE to PC in the liver.
In addition, @DMissa published research showing PC(0-38:4) is lower in ME/CFS LCLs.
I personally have the gene variant of PEMT rs12325817 which reduces the ability to upregulate PEMT expression in response to estrogen. I'm not sure if common PEMT variants like rs12325817 and rs7946 were looked at in the DecodeME study @Simon M @Chris Ponting
When I was ill with ME I used to get postprandial hypoglycemia at about 40 minutes after eating a meal, and starting to supplement phosphatidylcholine stopped this- I was wearing a continuous glucose monitor at the time so I could see the hypoglycemias. What is interesting is that for long before I developed ME at age 32 I had been sensitive to carbohydrates and would feel very sleepy after eating high glycemic index foods and this sensitivity to carbohydrates got progressively worse in my late 20s, which is interesting as estrogen in women decreases in late 20s/early 30s, which I may have been more vulnerable to with a PEMT variant which makes PEMT less responsive to estrogen.
There is not much research on how phosphatidylcholine affects insulin receptor sensitivity, but there is a study which indicates that reduced PC in the membrane can increase insulin receptor sensitivity, potentially contributing to faster glucose uptake which could have contributed to my post prandial hypoglycemia.
https://diabetesjournals.org/diabet.../Inhibiting-Phosphatidylcholine-Remodeling-in
The reason it's interesting to me is that this was one of the few issues I had when I was still a relatively healthy person, long before I developed ME which makes me think that reduced PC synthesis might be more likely to be a contributing root cause rather than a downstream consequence of whatever is causing ME.
My suspicion is that getting both Covid and then a head injury within 6 months of each other led to increased PLA2 activation which increased PC hydrolysis, and because I already had a problem with PC synthesis, this pushed me past a threshold to create a serious PC deficiency.